Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2.
J Dtsch Dermatol Ges
; 20(8): 1123-1124, 2022 08.
Article
in English
| MEDLINE | ID: covidwho-1886653
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pityriasis Rosea
/
COVID-19 Vaccines
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Dtsch Dermatol Ges
Journal subject:
Dermatology
Year:
2022
Document Type:
Article
Affiliation country:
Ddg.14784
Similar
MEDLINE
...
LILACS
LIS